Similar articles

• Procalcitonin-guided antibiotic therapy in COPD exacerbations: closer but not quite there.

  Martinez FJ, Curtis JL. Martinez FJ, et al. Chest. 2007 Jan;131(1):1-2. doi: 10.1378/chest.06-2567. Chest. 2007. PMID: 17218546 No abstract available.
• Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial.

  Christ-Crain M, Jaccard-Stolz D, Bingisser R, Gencay MM, Huber PR, Tamm M, Müller B. Christ-Crain M, et al. Lancet. 2004 Feb 21;363(9409):600-7. doi: 10.1016/S0140-6736(04)15591-8. Lancet. 2004. PMID: 14987884 Clinical Trial.
• Procalcitonin-guided antibiotic use in acute respiratory tract infections.

  Bollu M, Marte-Grau AC, Bobba RK. Bollu M, et al. Arch Intern Med. 2009 Apr 13;169(7):716. doi: 10.1001/archinternmed.2009.27. Arch Intern Med. 2009. PMID: 19365003 No abstract available.
• [Is procalcitonin determination for control of antibiotic therapy in acute respiratory infections of value?].

  Schütz P, Müller B, Briel M. Schütz P, et al. Praxis (Bern 1994). 2013 Mar 27;102(7):413-4. doi: 10.1024/1661-8157/a001241. Praxis (Bern 1994). 2013. PMID: 23531909 Review. German. No abstract available.
• [Procalcitonin as a biomarker in infections].

  Christ-Crain M. Christ-Crain M. Praxis (Bern 1994). 2007 Jun 20;96(25-26):1017-21. doi: 10.1024/1661-8157.96.25.1017. Praxis (Bern 1994). 2007. PMID: 17639964 Review. German. No abstract available.